Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors

NCT00007917 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: alvocidib
DRUG: gemcitabine hydrochloride

Sponsor

National Cancer Institute (NCI)